Characterization of a catalytic antibody for stereoselective ester hydrolysis—a catalytic residue and mode of product inhibition
Bioorganic & Medicinal Chemistry, ISSN: 0968-0896, Vol: 2, Issue: 6, Page: 457-468
1994
- 7Citations
- 2Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
A catalytic antibody which catalyzes stereoselective ester hydrolysis was characterized, and the role of a catalytic Arg residue is discussed in terms of product inhibition. A monoclonal antibody 1C7 generated against the phosphonate 1 was highly stereoselective for ( R )-isomer in hydrolyzing racemic ester 2. However, the reaction was almost stoichiometric due to strong inhibition by the product acid 3. One Arg residue in the antibody combining site was essential to the catalysis, and the same Arg was expected to play a dominant role in product inhibition by charge interaction with the negatively charged product acid. Indeed, the antibody experienced much less product inhibition with the hydrolysis of a carbonate ester 7, which yields a neutral alcohol 8 devoid of a negative charge, and exhibited at least 100 turnovers without any loss of activity. In addition, high stereoselectivity for ( R )-isomer was still retained. The amino acid sequence and computer modeling of the variable domain of 1C7 suggested that Arg 97 in the complementarity-determining region (CDR) of heavy chain was the putative catalytic residue.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/0968089694800154; http://dx.doi.org/10.1016/0968-0896(94)80015-4; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0028459112&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/8000868; https://linkinghub.elsevier.com/retrieve/pii/0968089694800154; http://dx.doi.org/10.1016/0968-0896%2894%2980015-4; https://dx.doi.org/10.1016/0968-0896%2894%2980015-4
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know